Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Stopping tamsulosin one month before cataract surgery reduces eye surgery complications in rats.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Autonomous robotic surgery is advancing but still requires human supervision for complex procedures.

Serum triglyceride levels are not linked to prostate cancer risk.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The normal human prostate does not significantly affect blood DHT levels.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Physical activity, height, and smoking affect prostate cancer risk.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Minoxidil increases calcium levels and kills prostate cancer cells independently of calcium.

Finasteride reduces prostate bleeding by affecting blood vessel growth.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

The compound was successfully made and shows potential for treating prostate cancer.